Investor Alert: Abbott Cooper PLLC Announces Investigation into Paratek Pharmaceuticals, Inc.; Urges Paratek Stockholders to Contact Abbott Cooper Regarding Their Legal Rights
09 Agosto 2023 - 3:37PM
Business Wire
Abbott Cooper PLLC announces that it is investigating Paratek
Pharmaceuticals, Inc. (NASDAQ: PRTK) (“Paratek” or the “Company”)
on behalf of the Company’s investors.
The investigation seeks to determine whether Franchise Group
stockholders have been injured due to any violations of fiduciary
duty or federal securities law in connection with Paratek’s
agreement to be acquired by affiliates of Gurnet Point Capital, LLC
and Novo Holdings A/S.
Paratek stockholders are encouraged to contact Abbott Cooper
PLLC by calling (475) 333-0674, emailing
ac@abbottlawyer.com or visiting our website at
www.abbottlawyer.com for additional information about
this investigation as well as their legal rights and
options.
Abbott Cooper PLLC is dedicated to shareholders’ rights and
empowering shareholders through strategic counsel and legal
advocacy. For additional information about Abbott Cooper PLLC,
please visit www.abbottlawyer.com.
Attorney advertising. Prior results do not guarantee a similar
outcome.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230809631795/en/
Abbott Cooper PLLC J. Abbott R. Cooper, Esq. (475)
333-0674 www.abbottlawyer.com
Paratek Pharmaceuticals (NASDAQ:PRTK)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Paratek Pharmaceuticals (NASDAQ:PRTK)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024